← Back to catalogue

Ristocetin Cofactor Abnormal Control Plasma

FDA UDI

Class II (US FDA UDI)

by Helena Laboratories, Corp.

Identity

Trade Name
Ristocetin Cofactor Abnormal Control Plasma FDA UDI
Generic Name
von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO) IVD, control FDA UDI
Model / Reference
5373 FDA UDI

Identifiers

Primary DI / UDI-DI
M52553730 FDA UDI
510(k) Number
K840329 FDA UDI
FDA Product Code
GGP FDA UDI
GMDN Term
von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO) IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7290 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO) IVD, control

Ristocetin Cofactor Abnormal Control Plasma by Helena Laboratories, Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO) IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5c55fafe-2eaa-45cd-b86a-5a12802cc742 34 fields · synced Jun 9, 2026